1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine
C97H85ClFN55O3 — CID 161230510
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine
1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine (PubChem CID 161230510) has the molecular formula C97H85ClFN55O3 and a molecular weight of 2123.58 g/mol. Its IUPAC name is 1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine |
|---|---|
| PubChem CID | 161230510 |
| Molecular Formula | C97H85ClFN55O3 |
| Molecular Weight | 2123.58 g/mol |
| Exact Mass | 2121.79 |
| IUPAC Name | 1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-amine;N-[4-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)phenyl]-4-fluorobenzamide;1-(6-chloropyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[6-(dimethylamino)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-morpholin-4-ylpyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-(6-propan-2-yloxypyridazin-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine;1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine;1-quinoxalin-2-ylpyrazolo[3,4-d]pyrimidin-4-amine |
| SMILES | CC(C)Oc1ccc(-n2ncc3c(N)ncnc32)nn1.CN(C)c1ccc(-n2ncc3c(N)ncnc32)nn1.Nc1ccc(-n2ncc3c(N)ncnc32)cc1.Nc1ncnc2c1cnn2-c1ccc(Cl)nn1.Nc1ncnc2c1cnn2-c1ccc(N2CCOCC2)nn1.Nc1ncnc2c1cnn2-c1ccc(NC(=O)c2ccc(F)cc2)cc1.Nc1ncnc2c1cnn2-c1ccccn1.Nc1ncnc2c1cnn2-c1cnc2ccccc2n1 |
| InChI | InChI=1S/C18H13FN6O.C13H14N8O.C13H9N7.C12H13N7O.C11H12N8.C11H10N6.C10H8N6.C9H6ClN7/c19-12-3-1-11(2-4-12)18(26)24-13-5-7-14(8-6-13)25-17-15(9-23-25)16(20)21-10-22-17;14-12-9-7-17-21(13(9)16-8-15-12)11-2-1-10(18-19-11)20-3-5-22-6-4-20;14-12-8-5-18-20(13(8)17-7-16-12)11-6-15-9-3-1-2-4-10(9)19-11;1-7(2)20-10-4-3-9(17-18-10)19-12-8(5-16-19)11(13)14-6-15-12;1-18(2)8-3-4-9(17-16-8)19-11-7(5-15-19)10(12)13-6-14-11;12-7-1-3-8(4-2-7)17-11-9(5-16-17)10(13)14-6-15-11;11-9-7-5-15-16(10(7)14-6-13-9)8-3-1-2-4-12-8;10-6-1-2-7(16-15-6)17-9-5(3-14-17)8(11)12-4-13-9/h1-10H,(H,24,26)(H2,20,21,22);1-2,7-8H,3-6H2,(H2,14,15,16);1-7H,(H2,14,16,17);3-7H,1-2H3,(H2,13,14,15);3-6H,1-2H3,(H2,12,13,14);1-6H,12H2,(H2,13,14,15);1-6H,(H2,11,13,14);1-4H,(H2,11,12,13) |
| InChIKey | UYRPYGMIRGVTQU-UHFFFAOYSA-N |
| XLogP | 8.00 |
| TPSA | 778.81 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 57 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 157 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2123.58 |
| LogP ≤ 5 | 8.00 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 57 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_no_alk(40)', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161230510 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.